Articles

Current antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.

Medicines Safety Update - Information for health professionals

The TGA will have limited operations from Friday 23 December 2022 until Tuesday 3 January 2023

Travellers will be able to bring up to 3-months supply of their medicine.

The Prescribing Medicines in Pregnancy database has now been updated.

Approval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations)

Before you take a weight loss supplement or medicine, there are things to consider.

Information about the TGA's safety monitoring of COVID-19 vaccines.

On 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19

On 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).

Make small changes to how you think about paracetamol.

Medicines Safety Update - Information for health professionals

Information about the TGA's safety monitoring of COVID-19 vaccines.

A warning to social media influencers and advertisers not to advertise this prescription medicine.

The TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia.

Listed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.

The TGA has issued an infringement notice of $2,664 to a NSW-based medical practitioner for alleged unlawful advertising of nicotine vaping products in a social media post.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).

Arrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act

On 25 October 2022, Natural Franchises Pty Ltd pleaded guilty in a Sydney court to over 200 offences of the Therapeutic Goods Act 1989 for the manufacture, supply and advertising of unapproved therapeutic goods.

The TGA is calling for anyone using a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine to see if they are affected by the recall action.

Information about the TGA's safety monitoring of COVID-19 vaccines.